Expensive Insulins, Pen Devices Dominate Diabetes Care in US

Analog insulins continue to represent more than 80% of prescriptions for type 2 diabetes in the US, despite rising costs and public scrutiny of pricing. Use of pen devices for delivery rose, too.

Related Keywords

Johns Hopkins University , Maryland , United States , Baltimore , American , Ritar Kalyani , , Health National Disease , Drug Administration , Division Of Endocrinology , American Diabetes Association , Metabolic Drugs Advisory Committee , Blood Institute , National Heart , Medscape Medical , Johns Hopkins University School , While Biosimilar Use , Therapeutic Index , Pen Devices Also , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Diabetes Mellitus , Insulin Therapy , Insulin Analog , Insulin Analogue , Drug Costs , Endocrinology , Ndocrine System , Biosimilars , Biosimilar Drugs , Follow On Biologics ,